Concentric Analgesics
PrivateLast Round
Convertible Debt
Jan 26, 2022
Total Funding Raised
$96M
Company Overview
Concentric Analgesics operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Convertible Debt round in January 2022.
Concentric Analgesics is a biopharmaceutical company that develops and commercializes non-opioid therapeutics for the management of postoperative and chronic pain.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Concentric Analgesics Comparables
Compare Concentric Analgesics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Allay Therapeutics | 88% | |
| Neumentum, Inc. | 87% | |
| AlgavitaBio, Inc. | 86% |
For institutional investors. Book with your work email.
Concentric Analgesics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Jan 26, 2022 | ||||
| Series B | May 21, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Concentric Analgesics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TD Securities | Series B |
| Blue Owl Capital | Series B |
| Kern Whelan Capital | Series B |
| Oracle Investment Management | Series B |
| Venrock | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors increased 117% MoM.
- Jan 26, 2022
Raised $20M in convertible debt.
For institutional investors. Book with your work email.
Concentric Analgesics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Concentric Analgesics's valuation, stock price, and market status.
Is Concentric Analgesics a public or private company?
Concentric Analgesics is a private company.
What is the current stock price of Concentric Analgesics?
Concentric Analgesics is a private company, so its shares have no public market price. Caplight tracks Concentric Analgesics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Concentric Analgesics worth (valuation)?
Valuation information for Concentric Analgesics is not publicly available.
Can I buy Concentric Analgesics stock?
Concentric Analgesics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Concentric Analgesics's last funding round?
Concentric Analgesics's most recent funding round was Convertible Debt on January 26, 2022.
Who are the main investors in Concentric Analgesics?
Key investors in Concentric Analgesics include Oracle Investment Management.
Will Concentric Analgesics IPO soon?
No public IPO plans have been announced for Concentric Analgesics.
How can I track Concentric Analgesics secondary market activity?
Caplight tracks bids, offers, and trades in Concentric Analgesics's shares on secondary markets.